Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future prospects for SonoVue and CPS.

David Cosgrove1

  • 1Imaging Sciences Department, Imperial College, London, UK. d.cosgrove@imperial.ac.uk

European Radiology
|February 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ER degradation for ER<sup>+</sup>/HER2- advanced or metastatic breast cancer: a phase 1 trial.

Nature communications·2025
Same author

Real-world treatment patterns and outcomes among patients initiating sequential regorafenib and trifluridine/tipiracil ± bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2).

Frontiers in oncology·2025
Same author

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network.

Journal of hepatocellular carcinoma·2025
Same author

COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.

Future oncology (London, England)·2024
Same author

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.

EClinicalMedicine·2023
Same author

Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.

European radiology·2020

High-frequency ultrasound contrast-enhanced (CEUS) imaging shows promise for small parts and intracavitary applications. New software enables excellent non-linear signals for assessing superficial structures like lymph nodes and thyroids.

Area of Science:

  • Medical Imaging
  • Ultrasound Technology
  • Biomedical Engineering

Background:

  • High-frequency ultrasound was previously limited for contrast-enhanced ultrasound (CEUS) due to resonance patterns of agents like SonoVue.
  • Advancements in transducer technology and software have overcome previous limitations.

Purpose of the Study:

  • To evaluate the potential of high-frequency CEUS for small parts and intracavitary applications.
  • To explore the utility of new software for generating non-linear signals at higher frequencies.

Main Methods:

  • Utilized recently developed Continuous Processing System (CPS) software.
  • Achieved non-linear signals at 7 MHz and higher frequencies.
  • Applied transabdominal transducers with CPS.

Related Experiment Videos

Main Results:

  • Demonstrated excellent non-linear signals at frequencies of 7 MHz and above.
  • Preliminary results indicate potential for assessing superficial lymph nodes, thyroid, parathyroid, and breast masses.
  • Identified potential fringe applications in pancreas, gallbladder, and spleen imaging.

Conclusions:

  • High-frequency CEUS is a promising technique for superficial and intracavitary imaging.
  • New CPS software enhances non-linear signal generation for improved diagnostic capabilities.
  • Further investigation is warranted for potential applications in abdominal organs.